Nuvectis Pharma, Inc. (NVCT)
NASDAQ·Healthcare·Biotechnology
$20.02
-4.26%
Mkt Cap $682.59M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (5 analysts)
$37.33
Range $33.00 – $40.00
Implied Upside
+86.5%
Consensus $37.33 vs current $20.02
NASDAQ·Healthcare·Biotechnology
$20.02
-4.26%
Mkt Cap $682.59M
Buy
4
Hold
0
Sell
0
Price Target (5 analysts)
$37.33
Range $33.00 – $40.00
+86.5%
Consensus $37.33 vs current $20.02